Atrion Corporation (ATRI) Financials
ATRI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 260.8 million | 17.9 million |
| 2023-09-30 | 264.8 million | 24.6 million |
| 2023-06-30 | 266.8 million | 25.9 million |
| 2023-03-31 | 261.4 million | 22.8 million |
ATRI Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 8.3 million | 212000 |
| 2023-09-30 | 2.4 million | 280000 |
| 2023-06-30 | -9.8 million | 632000 |
| 2023-03-31 | -3.2 million | 407000 |
ATRI Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 6.4 million |
| 2023-09-30 | 2.9 million |
| 2023-06-30 | 6.6 million |
| 2023-03-31 | 3.5 million |
ATRI Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 6.3 million | - | - |
| 2023-09-30 | 4.5 million | - | - |
| 2023-06-30 | 5.4 million | - | - |
| 2023-03-31 | 17.6 million | - | - |
ATRI Shares Outstanding
ATRI Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2.6 million | 1.6 million | 5.5 million | 2.5 million |
| 2023-09-30 | 3.1 million | 1.9 million | 5.5 million | 2.3 million |
| 2023-06-30 | 9.2 million | 1.6 million | 6.0 million | 2.3 million |
| 2023-03-31 | 7.5 million | 1.6 million | 6.3 million | 2.7 million |
ATRI Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 43.6 million | 27.3 million |
| 2023-09-30 | 41.9 million | 28.2 million |
| 2023-06-30 | 43.8 million | 26.6 million |
| 2023-03-31 | 40.0 million | 24.9 million |
ATRI
List: Contenders
Price: $424.19
Dividend Yield: 0.02%
Forward Dividend Yield: 2.07%
Payout Ratio: 72.85%
Dividend Per Share: 8.80 USD
Earnings Per Share: 11.02 USD
P/E Ratio: 31.40
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 3300
Ebitda: 48.8 millionMarket Capitalization: 702.8 million
Average Dividend Frequency: 4
Years Paying Dividends: 22
DGR3: 10.33%
DGR5: 11.00%
DGR10: 12.56%